COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,797 Articles (22,527 medRxiv, 8,270 bioRxiv)

Most recent first Previous |  Page 1561: Articles 15601-15610  | Next

Fraction of COVID-19 hospitalizations and deaths attributable to chronic diseases
Reyes-Sanchez, F., Basto-Abreu, A., Torres-Alvarez, R., Canto-Osorio, F., Gonzalez-Morales, R., Dyer, D., Lopez Ridaura, R., Zaragoza Jimenez, C. A., Rivera, J. A., Barrientos-Gutierrez, T.
10.1101/2021.04.12.21255346 — Posted: 2021-04-19
Assessing the Risk of Cascading COVID-19 Outbreaks from Prison-to-Prison Transfers
Parsons, T. L., Worden, L.
10.1101/2021.04.12.21255363 — Posted: 2021-04-19
How disease risk awareness modulates transmission: coupling infectious disease models with behavioral dynamics
Cascante-Vega, J., Torres-Florez, S., Cordovez, J., Santos-Vega, M.
10.1101/2021.04.13.21255395 — Posted: 2021-04-19
COVID transmission and contact tracing using WHO risk assement tool among frontline healthcare workers : Insights from a South Indian tertiary care centre
Moni, M., Kulirankal, K. G., Prasanna, P., Mary, A., Thomas, E. M., Sundaram, R. P., Babu, B., Bindu, V., Edathadathil, F., Bala, S., K V, B., Sathyapalan, D. T.
10.1101/2021.04.07.21255044 — Posted: 2021-04-19
Primary care and point-of-care testing during a pandemic: Clinician's perspectives on integrating rapid testing for COVID-19 into the primary care pathway
Kierkegaard, P., Hicks, T., Yang, Y., Lee, J., Hayward, G., Turner, P. J., Allen, A. J., Nicholson, B. D.
10.1101/2021.04.13.21255347 — Posted: 2021-04-19
Identification of natural SARS-CoV-2 infection in seroprevalence studies among vaccinated populations
Demmer, R. T., Baumgartner, B., Wiggen, T. D., Ulrich, A. K., Strickland, A. J., Naumchik, B. M., Bohn, B., Walsh, S., Smith, S., Kline, S., Stovitz, S. D., Yendell, S., Beebe, T., Hedberg, C.
10.1101/2021.04.12.21255330 — Posted: 2021-04-19
Ultra-fast, high throughput and inexpensive detection of SARS-CoV-2 seroconversion
Conzentino, M. S., Santos, T. P. C., Selim, K., Wagner, B., Alford, J. T., Deobald, N., Paula, N. M., Rego, F. G. M., Zanette, D. L., Aoki, M. N., Nardin, J. M., Huergo, M. C. C., Reis, R. A., Huergo, L.
10.1101/2021.04.13.21255396 — Posted: 2021-04-19
Differential Performance of CoronaCHEK SARS-CoV-2 Lateral Flow Antibody Assay by Geographic Origin of Samples
Baker, O. R., Grabowski, M. K., Galiwango, R. M., Nalumansi, A., Serwanga, J., Clarke, W., Hsieh, Y.-H., Rothman, R. E., Fernandez, R. E., Serwadda, D. M., Kagaayi, J., Lutalo, T., Reynolds, S. J., Kaleebu, P., Quinn, T. C., Laeyendecker, O.
10.1101/2021.04.12.21255284 — Posted: 2021-04-19
Sero-monitoring of health care workers reveals complex relationships between common coronavirus antibodies and SARS-CoV-2 severity
Gouma, S., Weirick, M. E., Bolton, M. J., Arevalo, C. P., Goodwin, E. C., Anderson, E. M., McAllister, C. M., Christensen, S. R., Dunbar, D., Fiore, D., Brock, A., Weaver, J., Millar, J., DerOhannessian, S., Frank, I., Rader, D. J., Wherry, E. J., Hensley, S. E.
10.1101/2021.04.12.21255324 — Posted: 2021-04-19
Effect of anakinra on mortality in COVID-19: a patient level meta-analysis
Kyriazopoulou, E., Huet, T., Cavalli, G., Gori, A., Kyprianou, M., Pickkers, P., Eugen-olsen, J., Clerici, M., Veas, F., Chatellier, G., Kaplanski, G., Netea, M. G., Pontali, E., Gattorno, M., Cauchois, R., Kooistra, E., Kox, M., Bandera, A., Beaussier, H., Mangioni, D., Dagna, L., van der Meer, J., Giamarellos-Bourboulis, E., Hayem, G., International collaborative group for Anakinra in COVID-19
10.1101/2021.04.13.21255411 — Posted: 2021-04-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).